News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,468 Results
Type
Article (59783)
Company Profile (161)
Press Release (659512)
Multimedia
Podcasts (130)
Webinars (23)
Section
Business (191243)
Career Advice (2803)
Deals (34876)
Drug Delivery (132)
Drug Development (79344)
Employer Resources (164)
FDA (16279)
Job Trends (15000)
News (330055)
Policy (31413)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (2805)
Academic (2)
Accelerated approval (38)
Adcomms (30)
Allergies (159)
Alliances (49912)
ALS (181)
Alzheimer's disease (1653)
Antibody-drug conjugate (ADC) (340)
Approvals (16574)
Artificial intelligence (619)
Autoimmune disease (194)
Automation (47)
Bankruptcy (318)
Best Places to Work (11689)
BIOSECURE Act (21)
Biosimilars (188)
Biotechnology (109)
Bladder cancer (168)
Brain cancer (66)
Breast cancer (651)
Cancer (5077)
Cardiovascular disease (426)
Career advice (2402)
Career pathing (42)
CAR-T (305)
CDC (50)
Celiac Disease (2)
Cell therapy (815)
Cervical cancer (40)
Clinical research (67938)
Collaboration (1916)
Company closure (6)
Compensation (838)
Complete response letters (66)
COVID-19 (2763)
CRISPR (107)
C-suite (965)
Cystic fibrosis (149)
Data (6532)
Decentralized trials (1)
Denatured (51)
Depression (148)
Diabetes (493)
Diagnostics (7008)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (41)
Drug discovery (289)
Drug pricing (195)
Drug shortages (28)
Duchenne muscular dystrophy (231)
Earnings (72477)
Editorial (62)
Employer branding (19)
Employer resources (145)
Events (111033)
Executive appointments (1061)
FDA (19599)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (26)
Funding (1580)
Gene editing (225)
Generative AI (56)
Gene therapy (631)
GLP-1 (958)
Government (4873)
Grass and pollen (8)
Guidances (384)
Healthcare (19244)
HIV (68)
Huntington's disease (46)
IgA nephropathy (78)
Immunology and inflammation (254)
Immuno-oncology (68)
Indications (132)
Infectious disease (3053)
Inflammatory bowel disease (203)
Inflation Reduction Act (14)
Influenza (128)
Intellectual property (263)
Interviews (531)
IPO (15948)
IRA (48)
Job creations (3671)
Job search strategy (1986)
JPM (68)
Kidney cancer (19)
Labor market (82)
Layoffs (603)
Leadership (39)
Legal (7186)
Liver cancer (91)
Longevity (20)
Lung cancer (667)
Lymphoma (381)
Machine learning (47)
Management (57)
Manufacturing (840)
MASH (174)
Medical device (14468)
Medtech (14534)
Mergers & acquisitions (20060)
Metabolic disorders (1295)
mRNA (190)
Multiple sclerosis (166)
NASH (16)
Neurodegenerative disease (335)
Neuropsychiatric disorders (92)
Neuroscience (2961)
Neurotech (1)
NextGen: Class of 2026 (6741)
Non-profit (4524)
Now hiring (33)
Obesity (598)
Opinion (320)
Ovarian cancer (172)
Pain (221)
Pancreatic cancer (244)
Parkinson's disease (292)
Partnered (35)
Patents (535)
Patient recruitment (557)
Peanut (63)
People (62428)
Pharmaceutical (33)
Pharmacy benefit managers (27)
Phase 1 (21560)
Phase 2 (30003)
Phase 3 (21851)
Pipeline (6062)
Policy (304)
Postmarket research (2417)
Preclinical (9233)
Press Release (69)
Prostate cancer (264)
Psychedelics (45)
Radiopharmaceuticals (309)
Rare diseases (911)
Real estate (6378)
Recruiting (69)
Regulatory (24037)
Reports (41)
Research institute (2614)
Resumes & cover letters (419)
Rett syndrome (31)
RNA editing (16)
RSV (77)
Schizophrenia (151)
Series A (274)
Series B (197)
Service/supplier (11)
Sickle cell disease (99)
Special edition (17)
Spinal muscular atrophy (160)
Sponsored (44)
Startups (3719)
State (2)
Stomach cancer (13)
Supply chain (97)
Tariffs (73)
The Weekly (77)
Vaccines (1050)
Venture capital (87)
Weight loss (369)
Women's health (94)
Worklife (23)
Date
Today (56)
Last 7 days (682)
Last 30 days (2767)
Last 365 days (29760)
2026 (5585)
2025 (30027)
2024 (34296)
2023 (38935)
2022 (49912)
2021 (54871)
2020 (53760)
2019 (47559)
2018 (36208)
2017 (32895)
2016 (32416)
2015 (38169)
2014 (30968)
2013 (27080)
2012 (28679)
2011 (28968)
2010 (27314)
Location
Africa (927)
Alabama (90)
Alaska (7)
Arizona (280)
Arkansas (14)
Asia (42796)
Australia (7935)
California (11169)
Canada (3294)
China (1150)
Colorado (484)
Connecticut (494)
Delaware (352)
Europe (97913)
Florida (1717)
Georgia (379)
Hawaii (3)
Idaho (62)
Illinois (933)
India (76)
Indiana (519)
Iowa (20)
Japan (459)
Kansas (130)
Kentucky (45)
Louisiana (34)
Maine (76)
Maryland (1398)
Massachusetts (8077)
Michigan (361)
Minnesota (663)
Mississippi (7)
Missouri (143)
Montana (37)
Nebraska (26)
Nevada (129)
New Hampshire (88)
New Jersey (3127)
New Mexico (31)
New York (3036)
North Carolina (1474)
North Dakota (9)
Northern California (5443)
Ohio (343)
Oklahoma (23)
Oregon (43)
Pennsylvania (2237)
Puerto Rico (24)
Rhode Island (44)
South America (1253)
South Carolina (71)
South Dakota (1)
Southern California (4411)
Tennessee (184)
Texas (1786)
United States (40495)
Utah (347)
Vermont (1)
Virginia (271)
Washington D.C. (73)
Washington State (939)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
719,468 Results for "royal melbourne institute of technology rmit".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Royal Biologics Announces Strategic Partnership with Jellagen (UK) to Bring Jellyfish-Derived Collagen Type Zero to the U.S. Regenerative Medicine Market
February 24, 2026
·
5 min read
Business
Oblique Therapeutics and the KTH Royal Institute of Technology (KTH) have entered into a strategic collaboration to analyse protein structures using supercomputers
Oblique Therapeutics, a leading biotechnology company specialising in the development of new drug candidates, is pleased to announce today that they have entered into an agreement with the KTH Royal Institute of Technology to utilise KTH’s state-of-the-art supercomputer resources for analysing protein structures.
June 18, 2024
·
3 min read
Press Releases
Alveo Technologies and Royal GD To Expand Poultry Testing Portfolio Beyond Avian Influenza
July 25, 2025
·
5 min read
Press Releases
Mitsubishi Electric and Indian Institute of Technology Hyderabad Sign MOU to Strengthen Industry-Academia Collaboration
February 12, 2026
·
1 min read
Press Releases
Arch Biopartners Expands Phase II Cardiac Surgery-Associated AKI Trial to Include Royal Columbian Hospital in British Columbia
November 6, 2025
·
5 min read
Press Releases
IGC Pharma Expands CALMA Phase 2 Trial to Island Health’s Royal Jubilee Hospital in Canada
September 3, 2025
·
4 min read
Press Releases
Parker Institute for Cancer Immunotherapy Announces Appointment of Bob Purcell as Chief Communications Officer
February 25, 2026
·
3 min read
Press Releases
Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology
January 28, 2026
·
5 min read
Press Releases
Alveo Technologies and Royal GD Form Long-Term Partnership to Expand Joint Offerings for Rapid, Molecular Animal Diagnostics at Point-of-Need
February 26, 2025
·
5 min read
Cell therapy
After Cell Therapy Retreat, Novo Offloads Technologies in Deepened Aspect Pact
Novo Nordisk pulled back from cell therapies last October, scrapping development of a type 1 diabetes therapy and laying off most employees working on this modality.
January 21, 2026
·
2 min read
·
Tristan Manalac
1 of 71,947
Next
